| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/02/1993 | WO1993016727A1 Mycobacterium vaccae for treatment of long term autoimmune conditions |
| 09/02/1993 | WO1993016726A2 Inactivated mycoplasma hyopneumoniae and uses therefor |
| 09/02/1993 | WO1993016725A1 Early antigen for autoimmune diabetes |
| 09/02/1993 | WO1993016724A1 Bystander suppression of autoimmune diseases |
| 09/02/1993 | WO1993016723A1 Purified vacuolating toxin from helicobacter pylori and methods to use same |
| 09/02/1993 | WO1993016722A1 Antigens protective against echinococcus granulosus infection and vaccines containing such antigens |
| 09/02/1993 | WO1993016709A1 Therapeutic domains of von willebrand factor |
| 09/02/1993 | CA2131028A1 Hepatitis c virus peptides |
| 09/02/1993 | CA2130997A1 Early antigen for autoimmune diabetes |
| 09/02/1993 | CA2130453A1 Heterologous gene expression in lactococcus, and the expression products threrefrom |
| 09/02/1993 | CA2130117A1 Mycobacterium vaccae for treatment of long term autoimmune conditions |
| 09/02/1993 | CA2129987A1 Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto |
| 09/02/1993 | CA2129982A1 Inactivated mycoplasma hyopneumoniae and uses therefor |
| 09/02/1993 | CA2129827A1 Analogous peptides of a viral protein internal image |
| 09/02/1993 | CA2117607A1 Defective packaging non-oncoviral vectors based on mpmv and hiv |
| 09/02/1993 | CA2117491A1 Car receptors and related molecules and methods |
| 09/02/1993 | CA2117480A1 Directed human immune globulin for the prevention and treatment of staphylococcal infections |
| 09/02/1993 | CA2117468A1 Ibv spike protein (2) |
| 09/01/1993 | EP0557535A1 HUMAN MONOCLONAL ANTIBODY AGAINST GLYCOPROTEIN IIb/IIIa |
| 09/01/1993 | EP0557467A1 Diagnostic testing for campylobacter jejuni or coli infection using antigens |
| 09/01/1993 | EP0557455A1 Recombinant feline coronavirus s proteins |
| 09/01/1993 | EP0557427A1 Human rotaviruses, vaccines and methods |
| 09/01/1993 | EP0557421A1 Method of preparing a diagnostic agent for detecting inflammations |
| 09/01/1993 | EP0557418A1 A $g(b)-TYPE TRANSFORMING GROWTH FACTOR |
| 09/01/1993 | EP0557388A1 Diagnosis and treatment of multiple sclerosis |
| 08/31/1993 | US5241053 Glycoprotein of Herpes simplex virus type 1 and heat-labile enterotoxin B subunit; enhanced absorption for immunization through nasal mucosa |
| 08/31/1993 | US5241052 Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses |
| 08/31/1993 | US5241047 Synthetic peptides and mixtures thereof for detecting HIV antibodies |
| 08/31/1993 | US5240909 Use of lactoferrin for treatment of toxic effects of endotoxins |
| 08/31/1993 | US5240706 Vaccine |
| 08/31/1993 | US5240705 Haemophilus paragallinarum vaccine |
| 08/31/1993 | US5240704 Vaccine, antibodies & antibody-containing compositions for inhibiting human dental caries induced by streptococcus mutans |
| 08/31/1993 | US5240703 Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof |
| 08/31/1993 | CA1321763C Monoclonal antibody specific to human pancreatic phospholipase a |
| 08/31/1993 | CA1321750C Therapeutic enzymes |
| 08/26/1993 | DE4206574C1 Fractionation method of parts of hepatitis C virus - by concn. of complexes of virus parts and lipoprotein(s) having low densities useful in hepatitis C virus detection and distinction of variants |
| 08/25/1993 | EP0556388A1 Antiviral agent |
| 08/25/1993 | EP0556333A1 Avirulent microbes and uses therefor: salmonella typhi |
| 08/25/1993 | EP0556292A1 Hepatitis c virus asialoglycoproteins |
| 08/25/1993 | EP0556285A1 Synergistic therapy with combinations of anti-tumor antibodies and biologically active agents |
| 08/25/1993 | EP0556182A1 Dna capable of site-specific integration into mycobacteria |
| 08/24/1993 | US5239078 Matrix metalloprotease inhibitors |
| 08/24/1993 | US5239056 Peptide fractions which induce antibodies protecting against the bovine leukemia virus, a process for obtaining such fractions, their coding sequences and vaccines made from such fractions |
| 08/24/1993 | US5238963 Treatment with compound to prevent crosslinking of glycosylation products |
| 08/24/1993 | US5238836 Genetic engineering; isolated DNA sequences |
| 08/24/1993 | US5238823 Interleukin-2-leukotoxin gene fusions and uses thereof |
| 08/24/1993 | CA1321582C Disulfur analogs of ll-e33288 antitumor agents |
| 08/19/1993 | WO1993016199A1 PEPTIDE FOR DIAGNOSING AND IMMUNIZING AGAINST T. cruzi INFECTION |
| 08/19/1993 | WO1993016186A1 Hybrid dna that codes for a subunit of a bacterial toxin with a hemolysin |
| 08/19/1993 | WO1993016185A2 Biosynthetic binding protein for cancer marker |
| 08/19/1993 | WO1993016184A1 Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5 |
| 08/19/1993 | WO1993016099A2 Dna sequences encoding novel growth/differentiation factors |
| 08/19/1993 | WO1993016087A2 Amadori reaction compounds and products, process for their manufacture, and their use |
| 08/19/1993 | WO1993015764A1 Treatment for inflammatory bowel disease |
| 08/19/1993 | WO1993015763A1 Vaccinal polypeptides |
| 08/19/1993 | WO1993015762A1 Feline infectious peritonitis vaccine and method of preparation |
| 08/19/1993 | WO1993015761A1 Malaria treatments |
| 08/19/1993 | WO1993015760A1 Dual carrier immunogenic construct |
| 08/19/1993 | WO1993015758A1 Composition and method of immunization with improved carrier and hapten-carrier vaccines |
| 08/19/1993 | WO1993015750A1 Use of synthetic peptides to induce tolerance to pathogenic t and b cell epitopes of autoantigens |
| 08/19/1993 | WO1993015749A1 Vaccines produced from herpes simplex virus light particles |
| 08/19/1993 | WO1993015747A1 A method of using cd4-containing molecules to substantially reduce the risk of occupational hiv transmission |
| 08/19/1993 | DE4219696A1 Hybrid-dna, plasmide, oligohybridpeptid und impfstoff Hybrid dna, plasmids, and oligohybridpeptid vaccine |
| 08/19/1993 | CA2372813A1 Biosynthetic binding protein for cancer marker |
| 08/19/1993 | CA2130106A1 Amadori reaction compounds and products, process for their manufacture, and their use |
| 08/19/1993 | CA2129445A1 Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5 |
| 08/19/1993 | CA2129351A1 Use of synthetic peptides to induce tolerance to pathogenic t and b cell epitopes of autoantigens |
| 08/19/1993 | CA2128698A1 Feline infectious peritonitis vaccine and method of preparation |
| 08/18/1993 | EP0556111A1 Hybrid protein complexes, their process of preparation, and their applications as an agent in diagnostic and in the therapeutic field or as a reagent relevant in medical approaches |
| 08/18/1993 | EP0556083A1 Process for the production of biologically active substances from milk and related raw materials |
| 08/18/1993 | EP0555894A1 Whooping cough vaccine |
| 08/18/1993 | EP0555880A2 The CD40CR receptor and ligands therefor |
| 08/18/1993 | EP0555425A1 Antibodies to streptolysin o derivatives and variants |
| 08/18/1993 | EP0555413A1 Methods and compositions for suppressing allograft rejection in mammals |
| 08/18/1993 | EP0555397A1 Polypeptide with kd hmfg differentiation antigen binding specificity |
| 08/18/1993 | EP0555291A1 Vaccinia vectors, vaccinia genes and expression products thereof |
| 08/18/1993 | EP0555231A1 REGULATION OF NEOPLASTIC CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR |
| 08/18/1993 | EP0555205A1 Dna encoding a growth factor specific for epithelial cells |
| 08/18/1993 | CN1075334A Reconstitued body vaccine and method of prepn. thereof |
| 08/17/1993 | US5237057 Monitoring drug abuse |
| 08/17/1993 | US5237054 Stabilized aqueous composition containing antibodies |
| 08/17/1993 | US5237053 Vaccines containing flagellar antigens |
| 08/17/1993 | US5237052 Useful as componetnts of acellular whooping cough vaccines |
| 08/17/1993 | US5237050 Bacterial plasmin receptors as fibrinolytic agents |
| 08/17/1993 | US5236905 In vitro method of inhibition of HIV using transforming growth factor-.beta. |
| 08/17/1993 | US5236836 Catalyst for the hydrolysis of peptide bond in vasoactive intestinal peptide |
| 08/17/1993 | US5236829 Method of producing monokine induced by gamma interferon |
| 08/17/1993 | US5236825 Complexing |
| 08/17/1993 | US5236708 Reduced-protein subunit vaccine for swine dysentery |
| 08/17/1993 | US5236706 Pharmaceutical preparation for the maturation of prothymocytes |
| 08/12/1993 | CA2089139A1 Complex hybrid proteins, method for preparing them, their applications as diagnostic agent, as agent intended for therapeutic use |
| 08/11/1993 | EP0554708A1 Thioether conjugates |
| 08/11/1993 | EP0554670A2 Specific antibodies against activated platelets, their production and applications in diagnostics and therapeutics |
| 08/11/1993 | EP0554656A1 Method for determination of antigenes or antibodies in presence of an immune complex |
| 08/11/1993 | EP0554624A1 Oligonucleotides, oligopeptides and determination system of HCV antibody subtype |
| 08/11/1993 | EP0554446A1 Monoclonal antibodies useful in therapy of HIV-1 infection |
| 08/11/1993 | EP0554414A1 Method for producing a subunit vaccine against the canine parvovirus and other related viruses |
| 08/11/1993 | EP0554401A1 Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120 |
| 08/11/1993 | EP0554389A1 Molecular clones of hiv-1 and uses thereof |
| 08/11/1993 | EP0554383A1 Blood coagulation protein antagonists and uses therefor |